What's sending this ASX 300 share 10% higher today?

Shareholders of this company will be smiling on Friday.

| More on:
A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The APM Human Services International Ltd (ASX: APM) share price is ending the week in style.

In morning trade, the ASX 300 share is up almost 11% to $2.06.

Why is this ASX 300 share rocketing higher?

Investors have been scrambling to buy this human services provider's shares today after it announced a major contract win in the UK.

According to the release, APM has been confirmed as the successful bidder to deliver Functional Assessment Services (FAS) on behalf of the Department for Work and Pensions (DWP) in the London, South-East, and East Anglia region.

The release notes that these services provide an assessment of the functional impact of disability and illness on an individual's daily life and their needs as a result of their health conditions.

The contract is for an initial five-year period and has a total value of $720 million or 384 million pounds. It is expected to commence in 2024 and includes an option for a two-year extension.

It is worth noting that this revenue won't all flow through to the bottom line, though. The company will require an investment in capital expenditure and working capital in FY 2023 and FY 2024 before the contract commences.

Speaking of profits, the ASX 300 share has also provided the market with an update on its performance and guidance for FY 2023.

Trading update

Pleasingly, APM continues to make positive progress in executing its strategy. It also continues to increase its average tenure across key programs through new contract awards, retenders, and extensions. This has seen the base tenure (excluding future options) being more than 3 years across its largest contracts.

As for its guidance, the company is expecting its FY 2023 underlying net profit after tax and before amortisation (NPATA) to be in the range of $175 million and $180 million.

This will be up from $166.3 million despite the impacts of lower client flow into Employment Services Programs, a shortage of qualified allied health professionals, and higher interest costs.

Commenting on the contract award, APM Group's CEO, Michael Anghie, said:

We look forward to partnering with the Department of Work and Pensions to deliver these important Functional Assessment Services. APM is one of the leading health service providers in Australia delivering Assessment Services across a wide range of sectors including Health, Disability and Aged Care.

The opportunity to deliver Functional Assessment Services demonstrates the strength of our local service delivery team, our reputation for service excellence, and our ability to leverage APM's expertise across regions and markets. The contract win continues the trend of APM executing its strategy and diversifying its business globally both geographically and in terms of service and revenue models.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended APM Human Services International. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »